| 溶解性 | DMSO |
| 存贮条件 | 储存温度-20°C |
| 生化机理 | Aleglitazar (R1439) is a dual peroxisome proliferator-activated receptor (PPAR) agonist, with affinity to PPARα and PPARγ. Aleglitazar is being developed for the treatment of type II diabetes; It is currently in phase III clinical trials. In preliminary clinical studies, Aleglitazar has been demonstrated to improve hyperglycemia and dyslipidemia in patients with type 2 diabetes mellitus. Aleglitazar has beneficial effects on both lipid and glucose parameters and may have a therapeutic role in modifying cardiovascular risk factors and improving glycemic control in patients with T2DM. Aleglitazar combines the lipid benefits of fibrates and the insulin-sensitizing benefits of thiazolidinediones. |
Aleglitazar,激动剂
Aleglitazar （订货以英文为准）
编号：A126806
CAS号：475479-34-6
| 产品名称 | Aleglitazar |
| 中文名称 | Aleglitazar,激动剂 |
| CAS号 | 475479-34-6 |
| 储存条件 | -20°C储存 |
搜索质检报告(COA)
搜索MSDS
相关产品
¥ 240.00
C416-01
¥ 240.00
C415-01
¥ 4250.00
2118S-100ul
¥ 989.00
R0581S-200units
小艺 
